News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,587 Results
Type
Article (87728)
Company Profile (824)
Press Release (778016)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233164)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91346)
Employer Resources (203)
FDA (18347)
Job Trends (17414)
News (397679)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (166)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18436)
Artificial intelligence (576)
Autoimmune disease (128)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (591)
Cancer (4610)
Cardiovascular disease (405)
Career advice (3565)
Career pathing (40)
CAR-T (288)
CDC (59)
Celiac Disease (1)
Cell therapy (780)
Cervical cancer (36)
Clinical research (76435)
Collaboration (1573)
Company closure (5)
Compensation (1055)
Complete response letters (65)
COVID-19 (2974)
CRISPR (93)
C-suite (726)
Cystic fibrosis (147)
Data (5721)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (490)
Diagnostics (7160)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99872)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134452)
Executive appointments (1009)
FDA (21155)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1424)
Gene editing (201)
Generative AI (59)
Gene therapy (616)
GLP-1 (1080)
Government (5417)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (271)
Immuno-oncology (34)
Indications (72)
Infectious disease (3242)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (214)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (641)
Lymphoma (357)
Machine learning (40)
Management (66)
Manufacturing (735)
MASH (164)
Medical device (14963)
Medtech (15002)
Mergers & acquisitions (22860)
Metabolic disorders (1274)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (320)
Neuropsychiatric disorders (85)
Neuroscience (2938)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (608)
Opinion (325)
Ovarian cancer (152)
Pain (183)
Pancreatic cancer (198)
Parkinson's disease (269)
Partnered (34)
Patents (462)
Patient recruitment (392)
Peanut (58)
People (66604)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23604)
Phase II (33179)
Phase III (24998)
Pipeline (3744)
Policy (318)
Postmarket research (3554)
Preclinical (10655)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (793)
Real estate (7435)
Recruiting (80)
Regulatory (28490)
Reports (65)
Research institute (2714)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (232)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1099)
Venture capital (76)
Weight loss (427)
Women's health (76)
Worklife (21)
Date
Today (153)
Last 7 days (650)
Last 30 days (2788)
Last 365 days (33372)
2025 (32123)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (85)
Alaska (7)
Arizona (324)
Arkansas (14)
Asia (51287)
Australia (9012)
California (10726)
Canada (3145)
China (1037)
Colorado (452)
Connecticut (478)
Delaware (320)
Europe (117902)
Florida (1572)
Georgia (347)
Hawaii (3)
Idaho (68)
Illinois (883)
India (62)
Indiana (516)
Iowa (22)
Japan (373)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7955)
Michigan (339)
Minnesota (623)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2937)
New Mexico (32)
New York (2872)
North Carolina (1526)
North Dakota (10)
Northern California (5042)
Ohio (326)
Oklahoma (22)
Oregon (52)
Pennsylvania (2177)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4119)
Tennessee (165)
Texas (1680)
United States (39059)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (903)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,587 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
December 11, 2025
·
7 min read
Press Releases
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 10, 2025
December 11, 2025
·
2 min read
Press Releases
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
December 11, 2025
·
6 min read
Press Releases
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
December 11, 2025
·
10 min read
Press Releases
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
December 11, 2025
·
8 min read
Press Releases
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - December 10, 2025
December 11, 2025
·
2 min read
Press Releases
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - December 10, 2025
December 11, 2025
·
1 min read
Press Releases
Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
December 11, 2025
·
5 min read
Press Releases
ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification
December 11, 2025
·
10 min read
IN PARTNERSHIP WITH ANAPTYSBIO
Beyond the Gluten-Free Diet: A New Era in Celiac Disease Treatment
In this episode of Denatured presented by AnaptysBio, Jennifer Smith-Parker speaks to Dr. Joe Murray, Mayo Clinic; Marilyn Gellar, the Celiac Disease Foundation; and Dr. Paul Lizzul, AnaptysBio, about the challenges and opportunities facing celiac disease treatment.
December 11, 2025
·
1 min read
·
Jennifer Smith-Parker
1 of 86,659
Next
